Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
It includes extensive molecular simulations of the receptor in its native membrane environment and the ensemble virtual screening accounting for its conformational mobility. In the case of dimeric or oligomeric receptors, the whole functional complex is modelled, and the tentative binding pockets are determined on and between the subunits to cover the whole spectrum of possible mechanisms of action.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P51449
UPID:
RORG_HUMAN
Alternative names:
Nuclear receptor RZR-gamma; Nuclear receptor subfamily 1 group F member 3; RAR-related orphan receptor C; Retinoid-related orphan receptor-gamma
Alternative UPACC:
P51449; Q5SZR9; Q8N5V7; Q8NCY8
Background:
Nuclear receptor ROR-gamma, also known as RAR-related orphan receptor C, plays a pivotal role in cellular differentiation, immunity, and metabolism. It binds DNA to regulate the expression of genes involved in circadian rhythm, lipid and glucose metabolism, and thymopoiesis. ROR-gamma's ability to modulate the transcription of clock genes and metabolic pathways underscores its significance in maintaining physiological homeostasis.
Therapeutic significance:
ROR-gamma's involvement in Immunodeficiency 42, characterized by increased susceptibility to infections, highlights its potential as a therapeutic target. Understanding the role of ROR-gamma could open doors to potential therapeutic strategies for enhancing immune responses and treating metabolic disorders.